Skip to main content

Main menu

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Peer reviewer login
  • Journal club
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Peer reviewer login
  • Journal club
  • Alerts
  • Subscriptions

Care of end-stage lung disease

A.K. Simonds
Breathe 2006 2: 314-320; DOI: 10.1183/18106838.0204.314
A.K. Simonds
Royal Brompton Hospital, Sydney Street, London SW3 6NP, UK. Fax: 44 2073518911; E-mail:
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: A.Simonds@rbht.nhs.uk
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Key points

  • Most patients with COPD die during acute exacerbations; in those who have been treated with acute NIV, almost 80% will require admission in the following year.

  • A comprehensive management plan for endstage lung disease patients needs to address symptom burden, provide information, support carers and assist with end-of-life planning.

  • Management should include optimisation of treatment of airflow obstruction and pulmonary rehabilitation. In some patients, pharmacotherapy for dyspnoea, panic attacks, depression and insomnia have a key role, but the importance of practical measures, including stairlifts, bath aids and social support, should not be underestimated.

  • Advance directives enable patients to give direction to the medical team about treatment preferences and should be part of routine care, especially in individuals who have already experienced an acute hypercapnic exacerbation.

Educational aims

  • To raise awareness of the symptom load of end-stage lung disease.

  • To examine trajectories of end-stage disease.

  • To discuss treatment strategies.

Summary Individuals with end-stage lung disease have a substantial symptom burden, which is often poorly addressed compared to patients with malignant disease. Recognition of the disease trajectory in the last few years of life enables a symptom-based approach that combines palliative care with active treatment of exacerbations where appropriate. Discussion of advance directives is helpful for both the patient and the physician.

  • ©ERS 2006

Breathe articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.

PreviousNext
Back to top
Vol 2 Issue 4 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Care of end-stage lung disease
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Care of end-stage lung disease
A.K. Simonds
Breathe Jun 2006, 2 (4) 314-320; DOI: 10.1183/18106838.0204.314

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Care of end-stage lung disease
A.K. Simonds
Breathe Jun 2006, 2 (4) 314-320; DOI: 10.1183/18106838.0204.314
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Idiopathic pulmonary fibrosis and lung cancer
  • Diagnosis and management of PH related to chronic respiratory disease
  • Pulmonary renal syndrome: a clinical review
Show more Reviews

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About Breathe

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Intructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN: 1810-6838
Online ISSN: 2073-4735

Copyright © 2023 by the European Respiratory Society